Filing Details
- Accession Number:
- 0000902664-25-001430
- Form Type:
- 13D Filing
- Publication Date:
- 2025-03-11 20:00:00
- Filed By:
- Cevian Capital
- Company:
- Autoliv Inc (NYSE:ALV)
- Filing Date:
- 2025-03-12
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Cevian Capital II GP LTD | 9,319,667 | 0 | 9,319,667 | 0 | 9,319,667 | 12.02% |
Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)
|
AUTOLIV INC (Name of Issuer) |
Common stock, par value $1.00 per share (Title of Class of Securities) |
052800109 (CUSIP Number) |
Norma O'Sullivan Cevian Capital II GP Limited, Whiteley Chambers, Don Street St. Helier, Y9, JE2 4TR 4401534828513 Ele Klein & Adriana Schwartz Schulte Roth & Zabel LLP, 919 Third Avenue New York, NY, 10022 212-756-2000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
03/10/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.


The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
CUSIP No. | 052800109 |
1 |
Name of reporting person
Cevian Capital II GP LTD | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
AF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
JERSEY
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
9,319,667.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
12.02 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IA, OO |
Comment for Type of Reporting Person:
Includes 3,021,159 Swedish Depositary Receipts representing 3,021,159 shares of Common Stock.
SCHEDULE 13D
|
Item 1. | Security and Issuer | |
(a) | Title of Class of Securities:
Common stock, par value $1.00 per share | |
(b) | Name of Issuer:
AUTOLIV INC | |
(c) | Address of Issuer's Principal Executive Offices:
3350 AIRPORT RD, OGDEN,
UTAH
, 84405. | |
Item 1 Comment:
This Amendment No. 8 ("Amendment No. 8") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission on March 1, 2018 (the "Original Schedule 13D", and the Original Schedule 13D as amended, the "Schedule 13D"), with respect to the common stock, par value $1.00 per share (the "Common Stock"), of Autoliv, Inc., a Delaware corporation (the "Issuer"). This Amendment No. 8 amends Items 5(a)-(c) as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 8 have the meanings set forth in the Schedule 13D. | ||
Item 5. | Interest in Securities of the Issuer | |
(a) | See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and percentages of the shares of Common Stock beneficially owned by the Reporting Person. The percentage used in this Schedule 13D is calculated based upon 77,535,354 shares of Common Stock outstanding, which is the difference obtained by (x) subtracting a total of 186,477 shares of Common Stock repurchased by the Issuer on March 3, 2025, March 4, 2025, March 5, 2025, March 6, 2025 and March 7, 2025, under the Issuer's share buyback program as disclosed on the Issuer's website, from (y) 77,721,831 shares of Common Stock outstanding as of February 28, 2025, as disclosed on the Issuer's website. | |
(b) | See rows (7) through (10) of the cover pages to this Schedule 13D for the number of shares of Common Stock as to which the Reporting Person has the sole power to vote or direct the vote and sole power to dispose or to direct the disposition. | |
(c) | No transactions in the shares of Common Stock or Swedish Depositary Receipts by the Reporting Person for the benefit of the Master Fund were made during the past sixty (60) days. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|